Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

News Daily News

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

December 29, 2021

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

News Daily News

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

Michael O'Riordan

November 29, 2021

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

News Daily News

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

November 25, 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

November 18, 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 08, 2021

COVID-19: TCTMD’s Dispatch for November Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 1

November 01, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

COVID-19: TCTMD’s Dispatch for September Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for September Week 5

September 27, 2021

Score May Help Guide VITT Management After COVID-19 Vaccination

News Daily News

Score May Help Guide VITT Management After COVID-19 Vaccination

September 23, 2021

Expired Cardiac Devices May Do Global Good, but Safety Unknown

News Features

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Yael L. Maxwell

August 26, 2021

Largest Study of VITT After COVID-19 Vaccination Digs Into Lab, Clinical Features

News Daily News

Largest Study of VITT After COVID-19 Vaccination Digs Into Lab, Clinical Features

August 11, 2021

Rare Clotting Complication Seen After mRNA Vaccine: Case Report

News Daily News

Rare Clotting Complication Seen After mRNA Vaccine: Case Report

June 28, 2021

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

News Daily News

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

June 14, 2021

CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself

News Daily News

CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself

June 10, 2021

COVID-19: TCTMD’s Daily Dispatch for June Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 2

June 07, 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

News Conference News ACC 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

May 17, 2021

VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms

News Daily News

VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms

May 06, 2021

COVID-19: TCTMD’s Daily Dispatch for May Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 1

May 02, 2021

AHA/ASA Offers Advice on Rare Blood Clots Seen After Vaccines for COVID-19

News Daily News

AHA/ASA Offers Advice on Rare Blood Clots Seen After Vaccines for COVID-19

April 30, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.